Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 28
1998 67
1999 104
2000 89
2001 74
2002 70
2003 94
2004 81
2005 83
2006 102
2007 110
2008 126
2009 121
2010 135
2011 142
2012 162
2013 146
2014 133
2015 128
2016 147
2017 113
2018 115
2019 117
2020 93
2021 88
2022 100
2023 58
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

2,565 results

Results by year

Filters applied: . Clear all
Page 1
Ulcerative colitis.
Le Berre C, Honap S, Peyrin-Biroulet L. Le Berre C, et al. Lancet. 2023 Aug 12;402(10401):571-584. doi: 10.1016/S0140-6736(23)00966-2. Lancet. 2023. PMID: 37573077 Review.
Multicenter survey on mesalamine intolerance in patients with ulcerative colitis.
Hiraoka S, Fujiwara A, Toyokawa T, Higashi R, Moritou Y, Takagi S, Matsueda K, Suzuki S, Miyaike J, Inokuchi T, Takahara M, Kato J, Okada H. Hiraoka S, et al. J Gastroenterol Hepatol. 2021 Jan;36(1):137-143. doi: 10.1111/jgh.15138. Epub 2020 Jun 27. J Gastroenterol Hepatol. 2021. PMID: 32525567
Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
Le Berre C, Roda G, Nedeljkovic Protic M, Danese S, Peyrin-Biroulet L. Le Berre C, et al. Expert Opin Biol Ther. 2020 Apr;20(4):363-378. doi: 10.1080/14712598.2019.1666101. Epub 2019 Sep 18. Expert Opin Biol Ther. 2020. PMID: 31498003 Review.
MMX mesalamine.
Baker DE. Baker DE. Rev Gastroenterol Disord. 2006 Summer;6(3):146-52. Rev Gastroenterol Disord. 2006. PMID: 16957657 Review.
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease.
Mehta RS, Mayers JR, Zhang Y, Bhosle A, Glasser NR, Nguyen LH, Ma W, Bae S, Branck T, Song K, Sebastian L, Pacheco JA, Seo HS, Clish C, Dhe-Paganon S, Ananthakrishnan AN, Franzosa EA, Balskus EP, Chan AT, Huttenhower C. Mehta RS, et al. Nat Med. 2023 Mar;29(3):700-709. doi: 10.1038/s41591-023-02217-7. Epub 2023 Feb 23. Nat Med. 2023. PMID: 36823301 Free PMC article.
Mesalamine-associated thrombocytopenia.
Farrell RJ, Peppercorn MA, Fine SN, Michetti P. Farrell RJ, et al. Am J Gastroenterol. 1999 Aug;94(8):2304-6. doi: 10.1111/j.1572-0241.1999.01324.x. Am J Gastroenterol. 1999. PMID: 10445572
The Association of Mesalamine With Kidney Disease.
Adiga A, Goldfarb DS. Adiga A, et al. Adv Chronic Kidney Dis. 2020 Jan;27(1):72-76. doi: 10.1053/j.ackd.2019.09.002. Adv Chronic Kidney Dis. 2020. PMID: 32147005 Review.
Mesalamine in the Initial Therapy of Ulcerative Colitis.
Chibbar R, Moss AC. Chibbar R, et al. Gastroenterol Clin North Am. 2020 Dec;49(4):689-704. doi: 10.1016/j.gtc.2020.07.002. Epub 2020 Sep 25. Gastroenterol Clin North Am. 2020. PMID: 33121689 Review.
5-Aminosalicylic acid.
Iida T, Onodera K, Nakase H. Iida T, et al. Nihon Rinsho. 2017 Mar;75(3):392-397. Nihon Rinsho. 2017. PMID: 30566780 English, Japanese.
2,565 results